购物车
全部删除
您的购物车当前为空
别名 LICOS, inducible T-cell co-stimulator ligand, ICOSLG, ICOS-L, ICOSL, ICOS ligand, GL50, CD275, B7RP-1, B7RP1, B7-h2, B7H2
Anti-ICOS ligand Antibody (6M734) 是一种 Mouse 抗体,靶向 ICOS ligand。Anti-ICOS ligand Antibody (6M734) 可用于 ELISA,ELISA(Det)。
Anti-ICOS ligand Antibody (6M734) 是一种 Mouse 抗体,靶向 ICOS ligand。Anti-ICOS ligand Antibody (6M734) 可用于 ELISA,ELISA(Det)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 20 μL | ¥ 590 | 5日内发货 | |
| 100 μL | ¥ 1,684 | 5日内发货 |
| 产品描述 | Anti-ICOS ligand Antibody (6M734) is a Mouse antibody targeting ICOS ligand. Anti-ICOS ligand Antibody (6M734) can be used in ELISA,ELISA(Det). |
| 别名 | LICOS, inducible T-cell co-stimulator ligand, ICOSLG, ICOS-L, ICOSL, ICOS ligand, GL50, CD275, B7RP-1, B7RP1, B7-h2, B7H2 |
| Ig Type | Mouse IgG1 |
| 克隆号 | 6M734 |
| 交叉反应 | Human |
| 特异性 | Human B7-H2/ICOSLG No cross-reactivity in ELISA with Human cell lysate (293 cell line) |
| 应用 | ELISAELISA(Det) |
| 推荐剂量 | ELISA: 1:1000-1:2000; ELISA(Det): 1:1000-1:10000 |
| 抗体种类 | Monoclonal |
| 宿主来源 | Mouse |
| 构建方式 | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human ICOS Ligand / B7-H2 / ICOSLG (rh ICOS Ligand / B7-H2 / ICOSLG; TMPY-01672; NP_056074.1; Met 1-Ser 258). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
| 纯化方式 | Protein A |
| 性状 | Liquid |
| 缓冲液 | 0.2 μm filtered solution in PBS |
| 研究背景 | Inducible co-stimulator ligand (ICOSL), also known as B7-H2, is a member of the B7 family of co-stimulatory molecules related to B7-1 and B7-2. It is a transmembrane glycoprotein with extracellular IgV and IgC domains and binds to ICOS on activated T cells, thus delivers a positive costimulatory signal for optimal T cell function. The structural features of ICOSL are crucial for its costimulatory function. The present study shows that ICOSL displays a marked oligomerization potential, resembling more like B7-1 than B7-2. B7-H2-dependent signaling may play an active role in a proliferative response rather than in cytokine and chemokine production. The CD28/B7 and ICOS/B7-H2 pathways are both critical for costimulating T cell immune responses. Deficiency in either pathway results in defective T cell activation, cytokine production, and germinal center formation.Cancer ImmunotherapyCo-stimulatory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint TargetsImmunotherapyTargeted Therapy |
| 偶联 | Unconjugated |
| 免疫原 | Recombinant Protein: Human ICOS Ligand / B7-H2 / ICOSLG protein (TMPY-01672) |
| 抗原种属 | Human |
| 研究领域 | Cancer Drug Targets |
| 储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| 运输方式 | Shipping with blue ice. |
评论内容